A new coronavirus with the ability to spread to humans similar to the Covid-19 pandemic has been discovered in China

New Bat Coronavirus Discovered with Potential to Infect Humans

A newly identified bat coronavirus, HKU5-CoV-2, has been found to have the ability to spread to humans, similar to the virus that caused the COVID-19 pandemic.

Discovery of HKU5-CoV-2

The virus was identified by a Chinese research team led by virologist Shi Zhengli, known for her extensive work on coronaviruses. Shi, a key researcher at the Wuhan Institute of Virology, has been at the center of discussions surrounding the origins of COVID-19, particularly regarding the lab leak theory, which she has denied.

Why This Matters

While hundreds of coronaviruses exist, only a few have been shown to infect humans, including SARS, SARS-CoV-2 (which causes COVID-19), and MERS (Middle East Respiratory Syndrome).

What makes HKU5-CoV-2 notable is its ability to bind to the ACE2 receptor—the same receptor used by SARS-CoV-2 to enter human cells. This increases its potential to infect humans compared to many other bat coronaviruses.

What is HKU5-CoV-2?

HKU5-CoV-2 belongs to the merbecovirus group, which also includes MERS-CoV. It shows a stronger ability to bind to human ACE2 receptors, making it more similar to SARS-CoV-2 and NL63, a common cold virus.

Researchers used Cryo-EM technology, a powerful imaging technique, to analyze how the virus binds to human cells. In laboratory tests, HKU5-CoV-2 successfully infected human cell cultures using mini-human organ models.

The study states:
"Bat merbecoviruses, which are phylogenetically related to MERS-CoV, pose a high risk of spillover to humans, either through direct transmission or via intermediate hosts."

Key Findings

The research was conducted by scientists from the Wuhan Institute of Virology, Guangzhou Laboratory, and Guangzhou Academy of Sciences and was published in the journal Cell.

The study highlights that while HKU5-CoV-2 has the biological capability to infect human cells, the actual risk of spillover to humans remains unknown.

Researchers found that:
"Authentic HKU5-CoV-2 infected human ACE2-expressing cell lines and human respiratory and enteric organoids. This study reveals a distinct lineage of HKU5-CoVs in bats that efficiently use human ACE2 and underscores their potential zoonotic risk."

What’s Next?

It remains unclear whether HKU5-CoV-2 will lead to disease in humans, but researchers emphasize the importance of monitoring its potential for transmission.

tastytrade logo+
Get the best broker for options trading and earn Unusual Whales discounted! in cash with an eligible account deposit at tastytrade. Get an Unusual Whales bonus when you deposit $2000. Offer expires 3/31/25. Certain restrictions, terms and conditions apply.
Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.